Neurogene

Biotech

Neurogene (NGNE) Stock Jumps 43% on $200 Million Financing Ahead of Early Study Data Release

November 4, 2024
0
A dropper squeezes a drop of liquid into a row of test tubes.

Neurogene (NASDAQ: NGNE), a genetic medicine company, saw its stock skyrocket by 43% on Monday following news of a $200…

Read More »
Back to top button